James B. Wood, Indiana University School of Medicine
Early test results look promising, and Pfizer has asked the FDA to review and authorize its vaccine for use in teens. That doesn’t mean putting away the face masks, though.
Marios Koutsakos, The Peter Doherty Institute for Infection and Immunity
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
Cyrus Sinai, University of North Carolina at Chapel Hill and Rob Fetter, Duke University
Solar-powered cold chain technologies can be game-changers in the fight against COVID-19 in resource-limited settings in sub-Saharan Africa and beyond.
Tony Heynen, The University of Queensland; Paul Lant, The University of Queensland, and Vigya Sharma, The University of Queensland
As immunisation emerges as the world’s primary weapon to combat COVID-19, much more work is needed to improve electricity access so vaccines can be refrigerated.
Divisions among Catholics have created doubts about the moral acceptability of one of the COVID-19 vaccines. An expert explains why there isn’t one ‘Catholic view’ on the issue.
The government should be explicit about what proportion of the population will need to be vaccinated to warrant border reopening. Australians could then measure progress towards that goal.
Sheena G. Sullivan, WHO Collaborating Centre for Reference and Research on Influenza and Kanta Subbarao, The Peter Doherty Institute for Infection and Immunity
Decades of experience with influenza offers insights into how we should handle new SARS-CoV-2 variants, and the threat they pose to vaccine effectiveness.
A vaccination queue-jumping scandal in Peru has caused a massive uproar in the South American country. It could also be a wake-up call for all nations.
Is Australia behind on its rollout of the COVID-19 vaccine? Yes. Will it catch up? Most likely, yes. But there are perils in trying to go too fast, and in overpromising on deadlines.
Data from clinical trials and the real world COVID vaccine rollout suggest blood clots occur no more frequently in vaccinated people than they do in the general population.
The risk of COVID escaping from hotel quarantine or a health-care setting will never be zero. But in NSW and Queensland, was everything possible done to minimise the risk?
The group has been at pains to stress it is not fundamentally about countering the ‘Chinese threat’. But of course, that is primarily what it is about.
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute